Agree with Kirpa above.
My own thinking is if results from the stage 2 of the pivotal trial are excellent then a commercial distribution partnership will follow in the months after that announcement.
These 2 events, if they occur, should result in a major re-rate of the company's share price and market cap.
Crazy and incredible to me that our market cap is still only $160 million although it is what it is.
EMvision Research Notes, page-2310
-
- There are more pages in this discussion • 271 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.02 |
Change
0.033(1.64%) |
Mkt cap ! $172.5M | |||
| Open | High | Low | Value | Volume |
| $1.98 | $2.02 | $1.94 | $41.93K | 21.40K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1272 | $1.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.03 | 4500 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| EMV (ASX) Chart |